contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-1505-hafnia-mapspeople-og-expres2ion

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

MapsPeople is a Software-as-a-Service (SaaS) company focusing on digital mapping for indoor navigation. The two primary revenue streams are 1) MapsIndoors which is MapsPeople’s own developed mapping solution for indoor navigation 2) Google Maps partnership with Google. MapsIndoors is the key segment with high double-digit growth rates, and the Google Maps segment is expected to be a more steady business going forward.

MapsPeople has a global presence with offices in Denmark, Germany, Singapore and United States, and customers include some of the largest brands in the world. The company has been listed at Nasdaq First North Premier in Denmark since June 2021.

MapsPeople

ExpreS2ion is a Danish-based biotech company listed in Sweden. The company develops a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer through the use of its non-viral cell-based expression system, ExpreS2, which is recognized for handling protein challenges. ExpreS2ion has developed Expres2, which is a technology platform for efficient and fast non-clinical development and production of complex proteins for new vaccines and diagnostics.

The company’s current primary product is the corona vaccine candidate, ABNCoV2 in phase 2, co-developed with its partner, AdaptVac of which ExpreS2ion owns 34%. The vaccine candidate has been licensed to Bavarian Nordic has global commercialization rights and responsibility for further clinical development of the vaccine and is expected to initiate phase 3 testing for the product candidate in the first half of 2022.

ExpreS2ion Biotech Holding

Hafnia is an international shipping company that specializes in the transportation of oil and chemical products. It started trading in Norway on the NOTC marketplace for unlisted shares in 2013. In 2019 Hafnia listed on the main market in Norway – Oslo Stock Exchange. The company, headquartered in Singapore, operates in the product tanker market, where it manages six pools combining self-owned and externally-owned vessels to benefit from economies of scale. The pools distribute profits/loss across all vessels in the pool, and Hafnia charges a commission for operating externally-owned tankers.

Hafnia’s six pools are categorized by vessel size/type, and reflect the fleet of vessels it owns. Its six pools are the: Handy Pool, MR Pool, LR Pool, LR2 Pool, Specialized Pool and Chemicals Pool. The MR and LR pools are considerably outsize the Handy and Specialized pools in terms of revenue and fleet size. Hafnia’s pools are primarily active in the product tanker spot market, but has also recently ramped up on chemical tankers.

In addition, Hafnia procures the bunker fuel for its partners at competitive prices for which it receives a commission.

Hafnia

Dagens aktienyheder med Hafnia, MapsPeople og ExpreS2ion

Hafnia har her til morgen offentliggjort sit regnskab for 1. kvartal 2025, der ikke overraskende viser en nedgang sammenholdt med niveauerne for et &#xe5;r siden, hvor raterne l&#xe5; p&#xe5; betydeligt h&#xf8;jere niveauer. Vi afholder event med Hafnia allerede i dag kl. 9:30 &#x2013; tilmeld dig her og l&#xe6;s mere om regnskabet: <a class="x1i10hfl xjbqb8w x1ejq31n xd10rxx x1sy0etr x17r0tee x972fbf xcfux6l x1qhh985 xm0m39n x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 xggy1nq x1a2a7pz x1s688f x1heor9g x1bvjpef xujl8zx" tabindex="-1" role="link" href="https://www.inderes.dk/analyst-comments/hafnia-kvartalsregnskab-for-q1-2025?fbclid=IwZXh0bgNhZW0CMTAAYnJpZBExUk9XcFY0OVFGcEl3bWtGZgEeNjFssyO_-BaiufM-SPY1kwKUjh__GYf63wB_bIQZqqZ8HheJWcs5wyO80gM_aem_3bDkJcJYxr3M1NXklMPEug" target="_blank" rel="nofollow noopener noreferrer">https://www.inderes.dk/analyst-comments/hafnia-kvartalsregnskab-for-q1-2025</a>
ExpreS2ion har her til morgen aflagt Q1 2025 regnskab, hvor oms&#xe6;tningen lander p&#xe5; SEK 2,9 mio. og bundlinjen viser en lille bedring med et underskud p&#xe5; SEK -11,4 mio. (SEK -12,9 mio. i Q1 2024). Selskabets kassebeholdning er p&#xe5; SEK 58 mio., og de gentager budskabet om, at har kapital til at gennemf&#xf8;re planlagte aktiviteter i 2025 og ind i 2026. Vi afholder senere i dag et event med ledelsen, hvor fokus mere vil v&#xe6;re p&#xe5; de seneste partneraftaler og tidslinjen samt &#xe6;ndringerne i deres fase 1 fors&#xf8;g p&#xe5; deres brystkr&#xe6;ftkandidat. Tilmeld dig her og stil dine sp&#xf8;rgsm&#xe5;l:&#xa0;<a class="x1i10hfl xjbqb8w x1ejq31n xd10rxx x1sy0etr x17r0tee x972fbf xcfux6l x1qhh985 xm0m39n x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 xggy1nq x1a2a7pz x1s688f x1heor9g x1bvjpef xujl8zx" tabindex="-1" role="link" href="https://www.inderes.dk/videos/expres2ion-biotechnologies-presentation-of-q1-2025?fbclid=IwZXh0bgNhZW0CMTAAYnJpZBExUk9XcFY0OVFGcEl3bWtGZgEev6uC03LDMy5arQ4SqQCOC8l7OjrjKbKcVUz5IeM08Wgob9F4HsidrE-lrYA_aem_bV8Ej6xJb-MwgpuBIWw1Ow" target="_blank" rel="nofollow noopener noreferrer">https://www.inderes.dk/videos/expres2ion-biotechnologies-presentation-of-q1-2025</a>
MapsPeople meddelte i g&#xe5;r, at selskabets private placement med et bruttoprovenu p&#xe5; ca. DKK 39 mio. er blevet registreret hos Erhvervsstyrelsen. Som meddelt tidligere i slutningen af april er aktierne tegnet af Apex Group Technologies (Apex) til en tegningskurs p&#xe5; DKK 0,9 per ny aktie. De nye aktier ventes at blive optaget til handel i morgen den 16. maj. Apex forventer samlet set at opn&#xe5; en ejerandel p&#xe5; mindst 51% og op til 64% af aktierne i MapsPeople. Den 27. maj afholder MapsPeople en ekstraordin&#xe6;r generalforsamling, hvor agendaen er valg af nye bestyrelsesmedlemmer samt et forslag om at afnotere aktierne i MapsPeople. MapsPeople forventer at afl&#xe6;gge regnskab for Q1 2025 i n&#xe6;ste uge den 21. maj. Samme dag om eftermiddagen kl. 14:00 vil selskabets CEO og CFO pr&#xe6;sentere resultaterne og svare p&#xe5; sp&#xf8;rgsm&#xe5;l. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l her: <a href="https://www.inderes.dk/videos/mapspeople-presentation-of-q1-2025-report">https://www.inderes.dk/videos/mapspeople-presentation-of-q1-2025-report</a>
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale.
/kasper Lihn, d. 15/05-2025 kl. 08:58.

Dagens aktienyheder 15/05: Hafnia, MapsPeople og ExpreS2ion

Stay up to date